Price: 4.69

Today's Change: -0.01

Today's Percent Change: 0.87%

Today's Volume: 12360

Average Daily Volume: 49402

52 week low: 2.82

52 week high: 6.07

Market cap: 77830000.0

EBITDA: -9570000.0

EBITDA / market_cap: -12.30%

Earnings per Share (EPS): -0.56

EPS / price: -11.94%

Dividend Yield: 0.0%

Dividend per share: 0.0

Book value: 1.49

Price to Book Ratio: 3.16

Price to Earnings (P/E) Ratio: 0.0

Price to Earnings Growth (PEG) Ratio: -0.58

Price to Sales (P/S) Ratio: 2.98

Short Ratio: 2.22

Exchange: "NCM"

Short term: DOWN (Previous: DOWN)

Mid term: DOWN (Previous: DOWN)

Long term: UP (Previous: UP)

Support: 4.91

Resistance: 5.03

Pivot point: 4.97

SMA 10: 5.10

SMA 50: 4.85

SMA 100: 4.22

RSI 10: 43.42

RSI 50: 53.01

RSI 100: 52.11

EMA 10: 5.14

EMA 50: 4.70

EMA 100: 4.02

HOLD

Based on 4 buy signals and 8 sell signals

Previous signal: hold

3.64

POSITIVE

ICAD
ICAD

@Stocktipstoday1: RT @ZoomStocks: #France Stocks: Auto $FR +3.3% #Renault +3.1% #Peugeot +2.1%. Fashion $KER +2.9%. Innovate/Engineer $ALT+2.2%. BioPharma $I…

@ZoomStocks: #France Stocks: Auto $FR +3.3% #Renault +3.1% #Peugeot +2.1%. Fashion $KER +2.9%. Innovate/Engineer $ALT+2.2%. BioP… https://t.co/w8KfNYJVY7

@bulletin_en: EPS for iCAD, Inc. $ICAD Expected At $-0.08 on March, 28 https://t.co/cFGTDEs6Rd

@StockflareUS: $ICAD: Forecast sales for iCAD Inc are now forecast to rise this year. (https://t.co/5LchAmPLp1)

@PharmaKaz: RT @TradersCom: Earnings Monday Mar 18 $SPX $NDX After Market Close AKEBIA THERAP $AKBA CATALYST PHARMA $CPRX DEL TACO RSTRNT $TACO HE…

@SeriousLeeStill: RT @TradersCom: Earnings Monday Mar 18 $SPX $NDX After Market Close AKEBIA THERAP $AKBA CATALYST PHARMA $CPRX DEL TACO RSTRNT $TACO HE…

@newswelldone: $ICAD: iCAD, Inc. (ICAD) CEO Michael Klein on Q4 2018 Results – Earnings …: https://t.co/6daGfenYh3

@SeekingAlpha: $ICAD - iCAD, Inc. (ICAD) CEO Michael Klein on Q4 2018 Results - Earnings Call Transcript https://t.co/8G1eSHUw8k

@ThePitBoss16: RT @TradersCom: Earnings Monday Mar 18 $SPX $NDX After Market Close AKEBIA THERAP $AKBA CATALYST PHARMA $CPRX DEL TACO RSTRNT $TACO HE…

@2nd2_N0NE: RT @eWhispers: #earnings scheduled after the close today TLRY $HQY $UNIT $STNE $TACO $SYNH $AMRS $EOLS $ADES $CPRX $AKBA $WAGE $REV $CUI…

@Smartinez005: RT @eWhispers: #earnings scheduled after the close today TLRY $HQY $UNIT $STNE $TACO $SYNH $AMRS $EOLS $ADES $CPRX $AKBA $WAGE $REV $CUI…

@Stock_News_Now: $ICAD: New SEC Filing for ICAD: Form 8-K (No. 0001193125-19-078257): https://t.co/zD1ViKQt70

@bthefirsttoknow: $ICAD iCAD Reports Fourth Quarter and Full-Year 2018 Financial Results https://t.co/LBQPBFfof3

@MarketCurrents: $ICAD - iCAD misses by $0.11, beats on revenue https://t.co/NDKHkpIwpu